Birchview Capital, LP
73 holdingsFiling period: 2026-03-31Current AUM: $159.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | KLAC | KLA CORPORATION | 19.9K | $29.3M | $3.6M | 2.28% | -2,000 | 2026-03-31 |
| 2 | BMY | BRISTOL-MYERS SQUIBB CO | 306.3K | $18.6M | $20.0M | 12.57% | +3.4K | 2026-03-31 |
| 3 | CMPX | COMPASS THERAPEUTICS INC | 1.47M | $7.8M | $2.8M | 1.76% | -127,071 | 2026-03-31 |
| 4 | LRCX | LAM RESEARCH CORPORATION | 36.0K | $7.7M | $10.5M | 6.63% | -4,329 | 2026-03-31 |
| 5 | STOK | STOKE THERAPEUTICS INC | 210.0K | $6.8M | $6.1M | 3.81% | -50,000 | 2026-03-31 |
| 6 | OVV | OVINTIV INC | 107.5K | $6.4M | $6.7M | 4.22% | -- | 2026-03-31 |
| 7 | NTLA | INTELLIA THERAPEUTICS INC | 445.4K | $5.7M | $4.8M | 2.99% | +130.0K | 2026-03-31 |
| 8 | GPCR | STRUCTURE THERAPEUTICS INC | 100.0K | $4.8M | $4.8M | 3.02% | +10.0K | 2026-03-31 |
| 9 | SLDB | SOLID BIOSCIENCES INC | 626.0K | $4.5M | $5.0M | 3.17% | -79,975 | 2026-03-31 |
| 10 | — | PROTHENA CORP PLC | 449.0K | $4.4M | $4.4M | 2.74% | +8.0K | 2026-03-31 |
| 11 | BDSX | BIODESIX INC | 286.8K | $4.2M | $6.1M | 3.82% | -- | 2026-03-31 |
| 12 | ACAD | ACADIA PHARMACEUTICALS INC | 171.0K | $3.8M | $4.4M | 2.78% | -- | 2026-03-31 |
| 13 | PTGX | PROTAGONIST THERAPEUTICS INC | 35.0K | $3.7M | $4.8M | 3.01% | -20,000 | 2026-03-31 |
| 14 | NBIX | NEUROCRINE BIOSCIENCES INC | 27.2K | $3.6M | $4.5M | 2.85% | -- | 2026-03-31 |
| 15 | OLMA | OLEMA PHARMACEUTICALS INC | 219.0K | $3.3M | $2.5M | 1.58% | -50,000 | 2026-03-31 |
| 16 | RLMD | RELMADA THERAPEUTICS INC | 409.4K | $2.8M | $2.2M | 1.37% | -- | 2026-03-31 |
| 17 | OCUL | OCULAR THERAPEUTIX INC | 320.0K | $2.7M | $2.6M | 1.64% | -- | 2026-03-31 |
| 18 | UTHR | UNITED THERAPEUTICS CORP | 4.5K | $2.7M | $2.3M | 1.46% | +1.5K | 2026-03-31 |
| 19 | NKTR | NEKTAR THERAPEUTICS | 31.0K | $2.2M | $2.2M | 1.38% | -- | 2026-03-31 |
| 20 | CLDX | CELLDEX THERAPEUTICS INC | 70.1K | $2.2M | $2.7M | 1.68% | -- | 2026-03-31 |
| 21 | — | NOVOCURE LTD | 202.3K | $2.2M | $2.2M | 1.39% | +50.2K | 2026-03-31 |
| 22 | EQT | EQT CORPORATION | 34.6K | $2.2M | $1.8M | 1.16% | -- | 2026-03-31 |
| 23 | PHAT | PHATHOM PHARMACEUTICALS INC | 195.0K | $2.2M | $1.7M | 1.07% | -- | 2026-03-31 |
| 24 | BCYC | BICYCLE THERAPEUTICS PLC | 463.6K | $2.2M | $1.8M | 1.12% | +899 | 2026-03-31 |
| 25 | CMPS | COMPASS PATHWAYS LTD | 375.0K | $2.1M | $4.3M | 2.67% | -- | 2026-03-31 |
← Scroll →
Page 1 of 3